4//SEC Filing
FORMELA JEAN FRANCOIS 4
Accession 0000899243-22-022238
CIK 0001835579other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:08 PM ET
Size
6.0 KB
Accession
0000899243-22-022238
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+13,419→ 13,419 totalExercise: $4.85Exp: 2032-06-09→ Common Stock (13,419 underlying)
Footnotes (2)
- [F1]This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the Reporting Person, a director of the Issuer, resigns from the Board or otherwise ceases to service as a director.
- [F2]The Reporting Person is a member of Atlas Venture Associates X, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001030575
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:08 PM ET
- Size
- 6.0 KB